PF-Atlas › Drugs › INS018_055

INS018_055

Idiopathic Pulmonary Fibrosis

Clinical trials
3
Developer
InSilico Medicine Hong Kong Limited

Overview

INS018_055 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.

INS018_055 clinical trials

NCT05938920 (Phase 2)NCT05154240 (Phase 1)NCT05975983 (Phase 2)

Explore related

All trialsResearch
Medical disclaimer. This page summarizes research about INS018_055 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.